全球静脉曲张治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

预计静脉曲张治疗市场将从 2025 年的 15.7 亿美元成长到 2034 年的 34.4 亿美元，2026 年至 2034 年的复合年增长率为 9.1%。

由于静脉疾病发病率的上升以及人们对微创治疗日益增长的兴趣，全球静脉曲张治疗市场正经历着稳定成长。治疗方法包括硬化疗法、经静脉雷射疗法和射频消融术。人口老化和久坐的生活方式是推动这项需求成长的重要因素。

主要成长要素包括非手术治疗技术的进步、诊断技术的改进以及医疗保健服务的普及。人们对美容手术日益增长的认知也推动了市场扩张。恢復期较短的门诊治疗越来越受欢迎。

由于雷射和导管技术的持续创新，前景依然乐观。新兴市场医疗基础设施的不断完善提供了成长机会。更重视早期诊断和病患教育将进一步加速市场发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球静脉曲张治疗市场：依产品划分

• 市场分析、洞察与预测
• 消融设备（射频消融/热消融、雷射消熔设备、超音波消融设备）
• 导管/硬化疗法和沾黏注射套装
• 压缩装置和服装
• 其他的

第五章：全球静脉曲张治疗市场：依治疗类型划分

• 市场分析、洞察与预测
• 静脉消融疗法
• 硬化疗法/沾黏注射
• 结扎和剥离
• 辅助治疗

第六章：全球静脉曲张治疗市场：依疾病类型划分

• 市场分析、洞察与预测
• 大隐静脉曲张
• 小隐静脉曲张
• 其他的

第七章 全球静脉曲张治疗市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院及门诊手术中心
• 专科诊所
• 其他的

第八章 全球静脉曲张治疗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • AngioDynamicsInc
  • Boston Scientific Corporation（BTG International Inc.）
  • DJO, LLC（Enovis Corporation）
  • Essity Aktiebolag（Publ）（BSN Medical）
  • F Care Systems NV
  • Medtronic Plc
  • Miravas（IPSA Group）
  • Mylan NV（Viatris, Inc.）
  • SIGVARIS Group
  • Teleflex Incorporated
  • VVT Medical
  • Wontech Co.Ltd

The Varicose Veins Treatment Market size is expected to reach USD 3.44 Billion in 2034 from USD 1.57 Billion (2025) growing at a CAGR of 9.1% during 2026-2034.

The Global Varicose Veins Treatment Market has witnessed steady growth due to increasing prevalence of venous disorders and rising awareness of minimally invasive procedures. Treatments include sclerotherapy, endovenous laser therapy, and radiofrequency ablation. Aging populations and sedentary lifestyles have significantly contributed to demand.

Major growth drivers include technological advancements in non-surgical treatments, improved diagnostic techniques, and expanding healthcare access. Growing cosmetic awareness also supports market expansion. Outpatient procedures with shorter recovery times are gaining popularity.

Future prospects remain positive as innovation in laser and catheter-based technologies continues. Emerging markets with improving healthcare infrastructure will offer growth opportunities. Increasing focus on early diagnosis and patient education will further drive market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Ablation Devices (Radiofrequency Ablation / Thermal Ablation, Laser Ablation Devices, Ultrasound Ablation Devices)
• Catheters / Kits for Sclerotherapy & Adhesion Injection
• Compression Devices / Garments
• Others

By Treatment Type

• Endovenous Ablation
• Sclerotherapy/Adhesion Injection
• Ligation/Stripping
• Supportive Treatment

By Disease Type

• Greater Saphenous Varicose Veins
• Small Saphenous Varicose Veins
• Others

By End-user

• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics
• Others

COMPANIES PROFILED

• AngioDynamics, Inc, Boston Scientific Corporation BTG International Inc, DJO, LLC Enovis Corporation, Essity Aktiebolag publ BSN Medical, F Care Systems NV, Medtronic plc, Miravas IPSA Group, Mylan NV Viatris, Inc, SIGVARIS Group, Teleflex Incorporated, VVT Medical, Wontech Co, Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Ablation Devices (Radiofrequency Ablation / Thermal Ablation, Laser Ablation Devices, Ultrasound Ablation Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Catheters / Kits for Sclerotherapy & Adhesion Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Compression Devices / Garments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment Type
• 5.2. Endovenous Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sclerotherapy/Adhesion Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ligation/Stripping Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Supportive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease Type
• 6.2. Greater Saphenous Varicose Veins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Small Saphenous Varicose Veins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Treatment Type
  • 8.2.3 By Disease Type
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Treatment Type
  • 8.3.3 By Disease Type
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Treatment Type
  • 8.4.3 By Disease Type
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Treatment Type
  • 8.5.3 By Disease Type
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Treatment Type
  • 8.6.3 By Disease Type
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VARICOSE VEINS TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AngioDynamicsInc
  • 10.2.2 Boston Scientific Corporation (BTG International Inc.)
  • 10.2.3 DJO, LLC (Enovis Corporation)
  • 10.2.4 Essity Aktiebolag (Publ) (BSN Medical)
  • 10.2.5 F Care Systems NV
  • 10.2.6 Medtronic Plc
  • 10.2.7 Miravas (IPSA Group)
  • 10.2.8 Mylan N.V. (Viatris, Inc.)
  • 10.2.9 SIGVARIS Group
  • 10.2.10 Teleflex Incorporated
  • 10.2.11 VVT Medical
  • 10.2.12 Wontech Co.Ltd